intoDNA

Booth 1484
Krakow, Poland
intoDNA provides its proprietary STRIDE technology for highly sensitive, direct, in situ detection of DNA damage. STRIDE combined with comprehensive solutions and expertise supports DDR targeted therapy development. The technology can be applied to a variety of biological materials at any stage of the drug development pipeline to enrich biopharmaceutical research.